Fecal microbiota transplantation in patients with cancer undergoing treatment

Clinical Journal of Oncology Nursing

Volumn 19, Issue 1, 2015, Pages 111-114

  Blackburn, Lisa M ^a   Bales, Andrea ^a   Caldwell, Mary ^a   Cordell, Lee ^a   Hamilton, Susan ^a   Kreider, Haley ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Clostridium difficile; Fecal microbiota transplantation; Stool transplantation

Indexed keywords

CLOSTRIDIUM INFECTIONS; FECAL MICROBIOTA TRANSPLANTATION; HUMAN; NEOPLASMS; OPPORTUNISTIC INFECTIONS; PEPTOCLOSTRIDIUM DIFFICILE; PROCEDURES;

CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; FECAL MICROBIOTA TRANSPLANTATION; HUMANS; NEOPLASMS; OPPORTUNISTIC INFECTIONS;

EID: 84922188642     PISSN: 10921095     EISSN: 1538067X     Source Type: Journal    
DOI: 10.1188/15.CJON.111-114     Document Type: Article

References (25)

1. Alonso, C. D., & Kamboj, M. (2014). Clostridium difficile infection (CDI) in solid organ and hematopoietic stem cell transplant recipients. Current Infectious Disease Reports, 16, 414. doi: 10. 1007/s11908-014-0414-0.
2. Bakken, J. S., Borody, T., Brandt, L. J., Brill, J. V., Demarco, D. C., Franzos, M. A.,. Surawicz, C. (2011). Treating Clostridium difficile infection with fecal microbiota transplantation. Clinical Gastroenterology and Hepatology, 9, 1044-1049. doi: 10. 1016/j. cgh. 2011. 08. 014.
3. Borody, T. J., & Campbell, J. (2012). Fecal microbiota transplantation: Techniques, applications, and issues. Gastroenterology Clinics of North America, 41, 781-803. doi: 10. 1016/j. gtc. 2012. 08. 008.
4. Brandt, L. J., Aroniadis, O. C., Mellow, M., Kanatzar, A., Kelly, C., Park, T.,. Surawicz, C. (2012). Long-term follow-up of colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection. American Journal of Gastroenterology, 107, 1079-1087. doi: 10. 1038/ajg. 2012. 60.
5. Cammarota, G., Ianiro, G., & Gasbarrini, A. (2014). Fecal microbiota transplantation for the treatment of Clostridium difficile infection: A systematic review. Journal of Clinical Gastroenterology, 48, 693-702. doi: 10. 1097. MCG. 0000000000000046.
6. Cohen, S. H., Gerding, D. N., Johnson, S., Kelly, C. P., Loo, V. G., McDonald, L. C.,. Wilcox, M. H. (2010). Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America. Infection Control and Hospital Epidemiology, 31, 431-455. doi: 10. 1086/651706.
7. Emanuelsson, F., Claesson, B. E., Ljungström, L., Tvede, M., & Ung, K. A. (2014). Faecal microbiota transplantation and bacteriotherapy for recurrent Clostridium difficile infection: A retrospective evaluation of 31 patients. Scandinavian Journal of Infectious Diseases, 46, 89-97. doi: 10. 3109/00365548. 2013. 858181.
8. Gough, E., Shaikh, H., & Manges, A. R. (2011). Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clinical Infectious Diseases, 53, 994-1002. doi: 10. 1093/cid/cir632.
9. Guo, B., Harstall, C., Louie, T., Veldhuyzen van Zanten, S., & Dieleman, L. A. (2012). Systematic review: Faecal transplantation for the treatment of Clostridium difficileassociated disease. Alimentary Pharmacology and Therapeutics, 35, 865-875. doi: 10. 1111/j. 1365-2036. 2012. 05033. x.
10. Kassam, Z., Lee, C. H., Yuan, Y., & Hunt, R. H. (2013). Fecal microbiota transplantation for Clostridium difficile infection: Systematic review and meta-analysis. American Journal of Gastroenterology, 108, 500-508. doi: 10. 1038/ajg. 2013. 59.
11. Kelly, C. R., de Leon, L., & Jasutkar, N. (2012). Fecal microbiota transplantation for relapsing Clostridium difficile infection in 26 patients: Methodology and results. Journal of Clinical Gastroenterology, 46, 145-149. doi: 10. 1097/MCG. 0b013e318234570b.
12. Kelly, C. R., Ihunnah, C., Fischer, M., Khoruts, A., Surawicz, C., Afzali, A.,. Brandt, L. (2014). Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients. American Journal of Gastroenterology, 109, 1065-1071. doi: 10. 1038/ajg. 2014. 133.
13. Khan, A., Raza, S., Batul, S. A., Khan, M., Aksoy, T., Baig, M. A., & Berger, B. J. (2012). The evolution of Clostridium difficile infection in cancer patients: Epidemiology, pathophysiology, and guidelines for prevention and management. Recent Patents on Anti-Infective Drug Discovery, 7, 157-170. doi: 10. 2174/157489112801619674.
14. King, R. N., & Lager, S. L. (2011). Incidence of Clostridium difficile infections in patients receiving antimicrobial and acidsuppression therapy. Pharmacotherapy, 31, 642-648. doi: 10. 1592/phco. 31. 7. 642.
15. Lee, C. H., Belanger, J. E., Kassam, Z., Smieja, M., Higgins, D., Broukhanski, G., & Kim, P. T. (2014). The outcome and long-term follow-up of 94 patients with recurrent and refractory Clostridium difficile infection using single to multiple fecal microbiota transplantation via retention enema. European Journal of Clinical Microbiology and Infectious Diseases, 33, 1425-1428. doi: 10. 1007/s10096-014-2088-9.
16. Loo, V. G., Poirier, L., Miller, M. A., Oughton, M., Libman, M. D., Michaud, S.,. Dascal, A. (2005). A predominantly clonal multiinstitutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. New England Journal of Medicine, 353, 2442-2449. doi: 10. 1056/NEJMoa051639.
17. Owens, C., Broussard, E., & Surawicz, C. (2013). Fecal microbiota transplantation and donor standardization. Trends in Microbiology, 21, 443-445. doi: 10. 1016/j. tim. 2013. 07. 003.
18. Samuel, B. P., Crumb, T. L., & Duba, M. M. (2014). What nurses need to know about fecal microbiota transplantation: Education, assessment, and care for children and young adults. Journal of Pediatric Nursing, 29, 354-361. doi: 10. 1016/j. pedn. 2014. 01. 013.
19. Smits, L. P., Bouter, K. E., de Vos, W. M., Borody, T. J., & Nieuwdorp, M. (2013). Therapeutic potential of fecal microbiota transplantation. Gastroenterology, 145, 946-953. doi: 10. 1053/j. gastro. 2013. 08. 058.
20. Sofi, A. A., Silverman, A L., Khuder, S., Garborg, K., Westerink, J. M., & Nawras, A. (2013). Relationship of symptom duration and fecal bacteriotherapy in Clostridium difficile infection-pooled data analysis and a systematic review. Scandinavian Journal of Gastroenterology, 48, 266-273. doi: 10. 3109/00365521. 2012. 743585.
21. U. S. Department of Health and Human Services, Food and Drug Administration, & Center for Biologics Evaluation and Research. (2013). Guidance for industry: Enforcement policy regarding investigational new drug requirements for use of fecal microbiota for transplantation to treat Clostridium difficile infection not responsive to standard therapies. Retrieved from http://www. fda. gov/biologicsbloodvaccines/guidance compl ianceregulatoryinformation/guidances/vaccines/ucm361379. htm.
22. van Nood, E., Vrieze, A., Nieuwdorp, M., Fuentes, S., Zoetendal, E. G., de Vos, W. M.,. Keller, J. J. (2013). Duodenal infusion of donor feces for recurrent Clostridium difficile. New England Journal of Medicine, 368, 407-415. doi: 10. 1056/NEJMoa1205037.
23. Vyas, D., L'Esperance, H. E., & Vyas, A. (2013). Stool therapy may become a preferred treatment of recurrent Clostridium difficile? World Journal of Gastroenterology, 19, 4635-4637. doi: 10. 3748/wjg. v19. i29. 4635.
24. Youngster, I., Russell, G. H., Pindar, C., Ziv-Baran, T., Sauk, J., & Hohmann, E. L. (2014). Oral, capsulized, frozen fecal microbiota transplantation for relapsing Clostridium difficile infection. JAMA, 312, 1772-1778. doi: 10. 1001/jama. 2014. 13875.
25. Zipursky, J. S., Sidorsky, T. I., Freedman, C. A., Sidorsky, M. N., & Kirkland, K. B. (2012). Patient attitudes toward the use of fecal microbiota transplantation in the treatment of recurrent Clostridium difficile infection. Clinical Infectious Diseases, 55, 1652-1658. doi: 10. 1093/cid/cis8.